SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kimia Biosciences informs about issuance of duplicate share certificates

20 Mar 2024 Evaluate

In reference to the earlier intimation dated 18.03.2024, Pursuant to Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Kimia Biosciences has informed that the Company has received the confirmation from its Registrar & Transfer Agent, Beetal Financial Computer Services, regarding the issuance of duplicate share certificates. The details of shareholders are enclosed. Pursuant to SEBI Circular No. SEBI/MIRSD/MIRSD_RTAMB/P/2022/8 dated January 25, 2022; a letter of confirmation will be issued to the securities holder/ claimant upon completion of necessary procedures regarding duplicate share certificates.

The above information is a part of company’s filings submitted to BSE. 

Kimia Biosciences Share Price

37.68 0.24 (0.64%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×